INGALLS & SNYDER LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$483
+4.1%
933,0000.0%0.02%
+4.5%
Q2 2023$464
+5.0%
933,000
-4.6%
0.02%
-4.3%
Q1 2023$442
-4.3%
978,000
+15.3%
0.02%
-8.0%
Q4 2022$462
-99.9%
848,0000.0%0.02%
-3.8%
Q3 2022$473,000
+0.9%
848,0000.0%0.03%
+4.0%
Q2 2022$469,000
+5.6%
848,000
-2.3%
0.02%
+25.0%
Q1 2022$444,000
-3.7%
868,000
-1.7%
0.02%
-4.8%
Q4 2021$461,000883,0000.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders